Kairos Pharma Ltd. (KAPA) Stock Price

0.8674 ▼ -0.1426 (-14.12%)
Open: 1.00 Vol: 846.42K Day's range: 0.8619 - 1.02 Nov 04, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KAPA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.88▼ 0.89▼ 0.90▼ 1.05▼ 1.08▼
MA10 0.89▼ 0.93▼ 0.96▼ 1.08▼ 1.25▼
MA20 0.93▼ 0.99▼ 1.02▼ 1.15▼ 1.11▼
MA50 1.03▼ 1.07▼ 1.08▼ 1.30▼ 1.10▼
MA100 1.07▼ 1.11▼ 1.14▼ 1.09▼ N/A    
MA200 1.13▼ 1.18▼ 1.17▼ 1.04▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ -0.011▼ -0.017▼ -0.017▼ -0.024▼
RSI 21.662▼ 19.671▼ 17.660▼ 31.237▼ 43.422▼
STOCH 9.485▼ 3.277▼ 0.702▼ 35.572     13.023▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -98.685▼ -99.559▼
CCI -128.181▼ -101.586▼ -129.752▼ -263.237▼ -123.020▼
Latest Filters Detected On KAPA
▼ BREAK $KAPA Price Breaks 60 Days Low Set Alert
▼ BREAK $KAPA Price Breaks 30 Days Low Set Alert
▼ BREAK $KAPA Price Breaks 20 Days Low Set Alert
▼ BREAK $KAPA Price Breaks 10 Days Low Set Alert
Kairos Pharma Ltd. News
Kairos Pharma Provides Shareholder Update
Tuesday, November 04, 2025 05:22 AM
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, provides an overview of key 2025 milestones and outlook into 2026 in a ...
Investornewsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) Highlights 2025 Milestones And Clinical Progress In CEO Letter To Shareholders
Monday, November 03, 2025 06:03 PM
Highlights 2025 Milestones And Clinical Progress In CEO Letter To Shareholders. Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing innovative cancer ...
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
Monday, October 20, 2025 07:13 PM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim efficacy data from its ongoing ...
KAPA historical stock data
date open high low close volume
04/11/25 1.00 1.02 0.8619 0.8674 846,424
03/11/25 1.10 1.10 1.00 1.01 400,800
31/10/25 1.11 1.13 1.09 1.13 92,100
30/10/25 1.10 1.145 1.07 1.14 138,700
29/10/25 1.16 1.16 1.10 1.10 142,133
28/10/25 1.12 1.16 1.12 1.14 178,403
27/10/25 1.15 1.16 1.12 1.15 303,900
24/10/25 1.09 1.13 1.08 1.09 127,200
23/10/25 1.05 1.13 1.04 1.09 175,100
22/10/25 1.14 1.14 1.02 1.06 606,700
Quote Details
52wk Low:0.40
52wk High:3.25
Vol:846.42K
Avg Vol(3m):17M
1Y Chng:-49.27%
1M Chng:-27.72%
Add to Watch List
More Information
Index N/A
Market Cap. 20.95M